The Herbal Pair <i>Daphniphyllum calycinum</i> – <scp> <i>Polygonum hydropiper</i> </scp> Alleviates Gastric Mucosal Injury via Regulating Autophagy and Targeting the <scp>TLR4</scp> / <scp>NF</scp> ‐ <scp>κB</scp> / <scp>NLRP3</scp> Pathway

(DCPH), known for its anti-inflammatory and antioxidant properties, has been shown to alleviate gastric mucosal injury. This study aimed to elucidate the mechanism by which DCPH alleviates gastric mucosal injury by integrating network pharmacology with both in vivo and in vitro experimental validation. The results indicated that DCPH treatment significantly increased the antioxidant capacity of the cells and decreased the expression of inflammation-related factors. DCPH suppressed macrophage M1 polarization while inducing apoptosis in damaged cells. Furthermore, DCPH diminished structural gastric mucosal damage and gastric inflammation. DCPH promotes autophagy by upregulating the expression of LC3II/I and Beclin1, and downregulating P62 accumulation, thereby inhibiting the TLR4/NF-κB/NLRP3 signaling pathway and M1 polarization, and reducing the release of inflammatory factors. However, these effects can be reversed by the autophagy inhibitor chloroquine (CQ). In conclusion, DCPH alleviates gastric mucosal injury via regulating autophagy and targeting TLR4/NF-κB/NLRP3, thereby offering insights for the treatment of gastrointestinal diseases.